Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients
- 12 April 2010
- journal article
- Published by Wiley in Experimental Dermatology
- Vol. 19 (5), 458-463
- https://doi.org/10.1111/j.1600-0625.2010.01069.x
Abstract
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are intraepidermal blistering skin diseases. PV is characterised by autoantibodies directed against desmoglein (Dsg) 3 and in patients with the mucocutaneous variant also against Dsg 1, whereas in PF, only Dsg 1 is targeted. Here, ectodomains of Dsg 3 and Dsg 1 were recombinantly expressed in a human cell line (HEK293) and applied as authentic solid phases in ELISA test systems. Autoantibodies against Dsg 3 and/or Dsg 1 could be detected in 71 (100%) of 71 PV sera and against Dsg 1 in 48 (96%) of 50 PF sera. Control sera showed reactivity with Dsg 3 and Dsg 1 in 0.2% and 0.7%, respectively, of 401 healthy blood donors and in 2.1% of 48 randomly selected patients with bullous pemphigoid. No reactivity with Dsg 1 and 3 was detected in 21 patients with linear IgA disease. For both pemphigus variants, a statistically significant correlation between clinical severity and autoantibody levels was observed as demonstrated for 10 PV and 5 PF patients. In conclusion, the use of the ectodomains of Dsg 3 and 1 as target antigens expressed in a human cell line resulted in sensitive and specific ELISA systems for both diagnosis and monitoring of PV and PF.Keywords
This publication has 34 references indexed in Scilit:
- Reliability and Convergent Validity of Two Outcome Instruments for PemphigusJournal of Investigative Dermatology, 2009
- Pathogenic Epitopes of Autoantibodies in Pemphigus Reside in the Amino-Terminal Adhesive Region of Desmogleins Which Are Unmasked by Proteolytic Processing of ProsequenceJournal of Investigative Dermatology, 2009
- Pathogenic Anti-Desmoglein MAbs Show Variable ELISA Activity because of Preferential Binding of Mature versus Proprotein Isoforms of Desmoglein 3Journal of Investigative Dermatology, 2009
- IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgarisExperimental Dermatology, 2007
- Desmoglein 1 and 3 enzyme‐linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activityJournal of the European Academy of Dermatology and Venereology, 2007
- Pemphigus, Bullous Impetigo, and the Staphylococcal Scalded-Skin SyndromeNew England Journal of Medicine, 2006
- Evaluation of desmoglein enzyme‐linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgarisInternational Journal of Dermatology, 2006
- Comparison of desmoglein ELISA and indirect immunofluorescence using two substrates (monkey oesophagus and normal human skin) in the diagnosis of pemphigusAustralasian Journal of Dermatology, 2005
- A comparison of anti‐desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgarisInternational Journal of Dermatology, 2004
- Induction of Pemphigus in Neonatal Mice by Passive Transfer of IgG from Patients with the DiseaseNew England Journal of Medicine, 1982